Morgan Stanley’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.92M | Sell |
1,422,346
-170,840
| -11% | -$591K | ﹤0.01% | 4076 |
|
|
2025
Q1 | $4.17M | Buy |
1,593,186
+292,416
| +22% | +$766K | ﹤0.01% | 4077 |
|
|
2024
Q4 | $5.36M | Buy |
1,300,770
+338,659
| +35% | +$1.4M | ﹤0.01% | 3930 |
|
|
2024
Q3 | $6.81M | Sell |
962,111
-280,167
| -23% | -$1.98M | ﹤0.01% | 3711 |
|
|
2024
Q2 | $8.1M | Buy |
1,242,278
+85,257
| +7% | +$556K | ﹤0.01% | 3475 |
|
|
2024
Q1 | $9.6M | Sell |
1,157,021
-300,387
| -21% | -$2.49M | ﹤0.01% | 3381 |
|
|
2023
Q4 | $16M | Buy |
1,457,408
+799,867
| +122% | +$8.81M | ﹤0.01% | 3534 |
|
|
2023
Q3 | $5.53M | Sell |
657,541
-119,926
| -15% | -$1.01M | ﹤0.01% | 3663 |
|
|
2023
Q2 | $9.76M | Buy |
777,467
+215,333
| +38% | +$2.7M | ﹤0.01% | 3187 |
|
|
2023
Q1 | $9.26M | Sell |
562,134
-1,807,210
| -76% | -$29.8M | ﹤0.01% | 3219 |
|
|
2022
Q4 | $35.4M | Buy |
2,369,344
+2,027,003
| +592% | +$30.3M | ﹤0.01% | 1805 |
|
|
2022
Q3 | $7.66M | Sell |
342,341
-283,783
| -45% | -$6.35M | ﹤0.01% | 3250 |
|
|
2022
Q2 | $10.5M | Buy |
626,124
+194,644
| +45% | +$3.26M | ﹤0.01% | 3023 |
|
|
2022
Q1 | $12.9M | Sell |
431,480
-92,013
| -18% | -$2.75M | ﹤0.01% | 2597 |
|
|
2021
Q4 | $16.1M | Buy |
523,493
+76,702
| +17% | +$2.36M | ﹤0.01% | 2399 |
|
|
2021
Q3 | $14.1M | Sell |
446,791
-122,854
| -22% | -$3.87M | ﹤0.01% | 2499 |
|
|
2021
Q2 | $20.8M | Buy |
569,645
+79,037
| +16% | +$2.89M | ﹤0.01% | 2106 |
|
|
2021
Q1 | $17M | Buy |
490,608
+361,849
| +281% | +$12.5M | ﹤0.01% | 2089 |
|
|
2020
Q4 | $5.35M | Buy |
128,759
+24,434
| +23% | +$1.02M | ﹤0.01% | 3185 |
|
|
2020
Q3 | $4.44M | Buy |
+104,325
| New | +$4.44M | ﹤0.01% | 2826 |
|